Figure 2.
Luteolin-7-O-glucoside (LUTG) maintained the redox homeostasis in cardiomyocytes. (A) Effect of LUTG on the viability of cardiomyocytes. (B) Effect of LUTG on the viability of the H/R treated cardiomyocytes. (C and D) Flow cytometry analysis for ROS generation. (E) LDH activity analysis. (F) Antioxidant enzyme CAT activity analysis. Control mock (CK); model group (MG); hypoxia/reoxygenation group (H/R); LUTG (10 and 20 µM) pretreatment groups: (H/R+10, H/R+20). Data were presented as mean ± standard deviation, n=4, *P<0.05 and **P<0.01 vs. CK; #P<0.05 and ##P<0.01 vs. H/R.